Citigroup
EXAS

Citigroup’s Exact Sciences EXAS Stock Holding History

Citigroup’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-146,862
Closed -$14.9M – 6082
2025
Q4 		$14.9M Sell
146,862
-58,593
-29% -$4.71M 0.01% 1270
2025
Q3 		$11.2M Sell
205,455
-27,707
-12% -$1.38M 0.01% 1400
2025
Q2 		$12.4M Sell
233,162
-1,048,743
-82% -$53.3M 0.01% 1246
2025
Q1 		$55.5M Buy
1,281,905
+495,780
+63% +$25.1M 0.03% 522
2024
Q4 		$44.2M Buy
786,125
+454,464
+137% +$28.3M 0.03% 572
2024
Q3 		$22.6M Sell
331,661
-52,145
-14% -$2.94M 0.01% 879
2024
Q2 		$16.2M Sell
383,806
-386,578
-50% -$21.3M 0.01% 986
2024
Q1 		$53.2M Buy
770,384
+589,281
+325% +$37.3M 0.03% 458
2023
Q4 		$13.4M Buy
181,103
+19,253
+12% +$1.26M 0.01% 1056
2023
Q3 		$11M Buy
161,850
+38,726
+31% +$3.29M 0.01% 1060
2023
Q2 		$11.6M Sell
123,124
-96,470
-44% -$7.53M 0.01% 1082
2023
Q1 		$14.9M Buy
219,594
+37,677
+21% +$2.42M 0.01% 956
2022
Q4 		$9.01M Sell
181,917
-114,074
-39% -$4.66M 0.01% 1189
2022
Q3 		$9.62M Buy
295,991
+69,999
+31% +$2.89M 0.01% 1164
2022
Q2 		$8.9M Sell
225,992
-5,148
-2% -$275K 0.01% 1214
2022
Q1 		$16.2M Buy
231,140
+43,091
+23% +$3.15M 0.01% 1039
2021
Q4 		$14.6M Buy
188,049
+9,286
+5% +$820K 0.01% 1183
2021
Q3 		$17.1M Buy
178,763
+37,224
+26% +$3.93M 0.01% 1094
2021
Q2 		$17.6M Sell
141,539
-39,029
-22% -$4.66M 0.01% 1070
2021
Q1 		$23.8M Buy
180,568
+13,378
+8% +$1.83M 0.02% 862
2020
Q4 		$22.2M Buy
167,190
+33,449
+25% +$4.05M 0.01% 974
2020
Q3 		$13.6M Buy
133,741
+29,388
+28% +$2.54M 0.01% 1146
2020
Q2 		$9.07M Buy
104,353
+19,382
+23% +$1.55M 0.01% 1374
2020
Q1 		$4.93M Sell
84,971
-38,869
-31% -$3.16M ﹤0.01% 1687
2019
Q4 		$11.5M Buy
123,840
+71,496
+137% +$6.29M 0.01% 1374
2019
Q3 		$4.73M Sell
52,344
-425,972
-89% -$48.5M ﹤0.01% 1996
2019
Q2 		$56.5M Buy
478,316
+20,151
+4% +$2.03M 0.05% 392
2019
Q1 		$39.7M Sell
458,165
-634,331
-58% -$54M 0.04% 483
2018
Q4 		$68.9M Sell
1,092,496
-142,304
-12% -$9.77M 0.07% 277
2018
Q3 		$97.5M Buy
1,234,800
+1,079,386
+695% +$70.4M 0.09% 202
2018
Q2 		$9.29M Buy
155,414
+141,483
+1,016% +$7.61M 0.01% 1332
2018
Q1 		$562K Sell
13,931
-2,073,513
-99% -$101M ﹤0.01% 3861
2017
Q4 		$110M Buy
2,087,444
+891,260
+75% +$47.6M 0.09% 204
2017
Q3 		$56.4M Buy
1,196,184
+122,828
+11% +$4.94M 0.05% 353
2017
Q2 		$38M Sell
1,073,356
-87,967
-8% -$2.72M 0.03% 459
2017
Q1 		$27.4M Sell
1,161,323
-3,362,553
-74% -$66.6M 0.02% 613
2016
Q4 		$60.4M Buy
4,523,876
+1,015,756
+29% +$16.4M 0.05% 333
2016
Q3 		$65.1M Sell
3,508,120
-857,188
-20% -$15.1M 0.06% 270
2016
Q2 		$53.5M Sell
4,365,308
-55,708
-1% -$420K 0.05% 312
2016
Q1 		$29.8M Buy
4,421,016
+121,030
+3% +$774K 0.03% 459
2015
Q4 		$39.7M Buy
4,299,986
+4,281,974
+23,773% +$39.8M 0.04% 441
2015
Q3 		$324K Buy
18,012
+12,950
+256% +$297K ﹤0.01% 4131
2015
Q2 		$151K Buy
5,062
+1,654
+49% +$41.6K ﹤0.01% 4672
2015
Q1 		$76K Buy
3,408
+127
+4% +$3.22K ﹤0.01% 5233
2014
Q4 		$89K Sell
3,281
-47,990
-94% -$1.17M ﹤0.01% 5325
2014
Q3 		$994K Sell
51,271
-108,720
-68% -$1.99M ﹤0.01% 3016
2014
Q2 		$2.73M Buy
159,991
+148,595
+1,304% +$2.05M ﹤0.01% 2265
2014
Q1 		$162K Sell
11,396
-12,511
-52% -$169K ﹤0.01% 4541
2013
Q4 		$280K Buy
23,907
+23,758
+15,945% +$273K ﹤0.01% 4352
2013
Q3 		$2K Sell
149
-3,502
-96% -$44.9K ﹤0.01% 6586
2013
Q2 		$51K Buy
+3,651
New +$39.7K ﹤0.01% 5372

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Citigroup's EXAS Position: Q1 2026 in Review

Citigroup sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 146,862 shares — an estimated $14.9M sold.

Citigroup first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $110M in Q4 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Citigroup reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 146,862 Exact Sciences shares in Q1 2026, an estimated $14.9M.
  • Citigroup first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Citigroup's Exact Sciences position peaked at $110M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.